MINNEAPOLIS — A reduced risk for death may balance out concerns about hyperkalemia when treating heart failure with renin-angiotensin system (RAS) inhibitors and mineralocorticoid receptor antagonists ...
Please provide your email address to receive an email when new articles are posted on . PCI was not cost-effective vs. optimal medical therapy alone in patients with CAD and HF. Intervention conferred ...
Key opinion leaders explore the necessary synergy between payors and providers for optimizing bispecific therapy. This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild, PharmD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results